Wednesday, April 24, 9:00 – 10:30 am
Auditorium Léon Hirsch
Chairs: Jonathan Bock (USA) – Nikki Johnston (USA)
- Is HEMII-pH the gold-standard diagnostic tool for LPR? – Jennifer Aoun (Belgium)
- Why does the clinical presentation and treatment response of patients with suspected LPR vary? – Inna Husain (USA)
- How does pepsin cause mucosal damage in the context of weakly or nonacid refluxate? – Tina Samuels (USA)
- What is the status of pepsin inhibitors for the treatment of LPR? – Nikki Johnston (USA)
- What is the evidence of surgical fundoplication and Linx system in gastro-esophago-laryngopharyngeal reflux? – Edgar F. Figueredo (USA)
- What is the role of the UES in LPR? – David M. Richards (USA)